Literature DB >> 21082878

Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action.

Joseph N Jarvis, Stephen D Lawn, Robin Wood, Thomas S Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21082878     DOI： 10.1086/657405

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

1.  Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.

Authors:  Joseph N Jarvis; Graeme Meintjes; Kevin Rebe; Gertrude Ntombomzi Williams; Tihana Bicanic; Anthony Williams; Charlotte Schutz; Linda-Gail Bekker; Robin Wood; Thomas S Harrison
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

2.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

3.  HIV-Related Opportunistic Infections Are Still Relevant in 2015.

Authors:  Henry Masur
Journal:  Top Antivir Med       Date:  2015 Aug-Sep

4.  Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

Authors:  Jennie McKenney; Sean Bauman; Brandon Neary; Roger Detels; Audrey French; Joseph Margolick; Brian Doherty; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2014-11-24       Impact factor: 9.079

Review 5.  Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.

Authors:  Radha Rajasingham; David B Meya; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

6.  Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.

Authors:  Admasu Tenna Mamuye; Ethan Bornstein; Obsie Temesgen; Henry M Blumberg; Russell R Kempker
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 7.  Cryptococcal infections: changing epidemiology and implications for therapy.

Authors:  Ricardo M La Hoz; Peter G Pappas
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

8.  Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.

Authors:  Diana Faini; Aneth Vedastus Kalinjuma; Andrew Katende; Gladys Mbwaji; Dorcas Mnzava; Amina Nyuri; Tracy R Glass; Hansjakob Furrer; Christoph Hatz; David R Boulware; Emilio Letang
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

9.  Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.

Authors:  Radha Rajasingham; Melissa A Rolfes; Kate E Birkenkamp; David B Meya; David R Boulware
Journal:  PLoS Med       Date:  2012-09-25       Impact factor: 11.069

10.  Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.

Authors:  Elissa K Butler; David R Boulware; Paul R Bohjanen; David B Meya
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.